Northwestern University: Liver Neoplasms trials

The registry lists 10 Liver Neoplasms studies with Northwestern University as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 2Phase 2 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Defining the Ablative Dose for Y-90 TARERecruitingNCT07586046Phase 2
• A2ALL-Patients Safety System Improvements in Living Donor Liver TransplantationCompletedNCT02073435Results posted
• Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or SurgeryCompletedNCT00956930Phase 2Results posted
• Optimizing Y90 Therapy for Radiation LobectomyActive, not recruitingNCT04390724
• Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)CompletedNCT00866957
• Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver MetastasesCompletedNCT00858429Phase 1
• Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver CancerCompletedNCT00739167
• Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00532740
• Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00530010
• Epirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaCompletedNCT00057980Phase 1/2